-
15/03/2018
HRA Pharma completes acquisition of Lysodren®
-
21/09/2017
HRA Pharma completes acquisition of Compeed®
-
27/07/2017
HRA Pharma signs agreement to acquire the Compeed® brand from CILAG GmbH International
-
03/07/2017
HRA Pharma appoints Martyn Hilton as Global Commercial Director
-
26/06/2017
Restricted access to emergency contraception in Poland is a backwards step for women’s reproductive health rights